In CAD, treat-to-target statins were noninferior to high-intensity statins for a composite clinical outcome
- PMID: 37399550
- DOI: 10.7326/J23-0041
In CAD, treat-to-target statins were noninferior to high-intensity statins for a composite clinical outcome
Abstract
Hong SJ, Lee YJ, Lee SJ, et al; LODESTAR Investigators. Treat-to-target or high-intensity statin in patients with coronary artery disease: a randomized clinical trial. JAMA. 2023;329:1078-1087. 36877807.
Conflict of interest statement
Comment on
-
Treat-to-Target or High-Intensity Statin in Patients With Coronary Artery Disease: A Randomized Clinical Trial.JAMA. 2023 Apr 4;329(13):1078-1087. doi: 10.1001/jama.2023.2487. JAMA. 2023. PMID: 36877807 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous